Publication | Open Access

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Metabolic SyndromeLipid DisorderHomozygous Familial HypercholesterolaemiaCardiovascular DiseaseMedicineDiabetesHyperlipidemiaPharmacologyAtherosclerosisDyslipidemia